Skip to main content
. 2017 Nov 17;4(4):111–122. doi: 10.2217/hep-2017-0019

Table 1. . Candidate biomarkers and phase of biomarker development.

Biomarker Phase I Phase II Phase III Phase IV Phase V
AFP         X

Osteopontin     X    

Midkine     X    

GALAD score     X    

AFP-L3   X      

Dickkopf-1   X      

DCP   X      

GPC3   X      

α-1-Fucosidase   X      

Golgi protein-73   X      

Squamous cell carcinoma antigen   X      

miRNA X X      

Metabolomics X        

Proteomics X X      

Cell-free DNA X        

AFP: α-Fetoprotein; DCP: Des-carboxyprothrombin; GPC3: Glypican-3.